title: Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
authors: Clinical Biochemistry, Canterbury Health Laboratories, PO Box 151, Christchurch, New Zealand. richard.king@cdhb.govt.nz
authors: Richard I
authors: RI
authors: King
authors: Russell S
authors: RS
authors: Scott
authors: Christopher M
authors: CM
authors: Florkowski
authors: Andrew D
authors: AD
authors: Laurie
authors: Nicola
authors: N
authors: Reid
authors: Peter M
authors: PM
authors: George
mesh_terms: D000293:Adolescent; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D001384:Azetidines / Q000008:administration & dosage; D001781:Blood Component Removal / Q000379:methods*; D008078:Cholesterol, LDL / Q000097:blood* / Q000187:drug effects; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D011743:Pyrimidines / Q000008:administration & dosage; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000008:administration & dosage
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D008078:Cholesterol, LDL; D005464:Fluorobenzenes; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000069438:Ezetimibe